61
Sylvia L Seroff, Noymi V Yam, Atul D Ayer, Padmanabh P Bhatt, Michael A Desjardin, Andrew C Lam, David E Edgren, Phillip R Nixon: Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing. ALZA Corporation, Robert R Neller, May 14, 2002: US06387403 (5 worldwide citation)

Dosage forms and methods for providing sustained release of reboxetine are provided. The sustained release dosage forms provide therapeutically effective average steady-state plasma reboxetine concentrations when administered once per day. This once-a-day dosing regimen results in only one peak plas ...


62
Patrick S L Wong, George V Guittard, Atul D Ayer: Pentoxifylline therapy and method of use. ALZA Corporation, Paul L Sabatine, Mary Ann Dillahunty, Felissa H Cagan, February 18, 1997: US05603954 (3 worldwide citation)

A dosage form is disclosed for delivering pentoxifylline to a patient in need of pentoxifylline therapy. A method is discussed for delivery pentoxifylline to a patient at a dosage form controlled rate over an extended period of time.


63
Patrick S L Wong, George V Guittard, Atul D Ayer: Pentoxifylline therapy. ALZA Corporation, Paul L Sabatine, Felissa H Cagan, Richard T Ito, July 2, 1996: US05532003 (3 worldwide citation)

A dosage form is disclosed for delivering pentoxifylline to a patient in need of pentoxifylline therapy. A method is discussed for delivery pentoxifylline to a patient at a dosage form controlled rate over an extended period of time.


64
Andrew C Lam, Padmaja Shivanand, Atul D Ayer, Zahedeh Hatamkhany, Suneel K Gupta, Diane R Guinta, Carol A Christopher, Samuel R Saks, Lawrence G Hamel, Jeri D Wright, Richard G Weyers: Methods and devices for providing prolonged drug therapy. Alza Corporation, Baker & Hostetler, May 12, 2015: US09029416 (2 worldwide citation)

Methods and devices for maintaining a desired therapeutic drug effect over a prolonged therapy period are provided. In particular, oral dosage forms that release drug within the gastrointestinal tract at an ascending release rate over an extended time period are provided. The dosage forms may additi ...


65
Andrew C Lam, Padmaja Shivanand, Atul D Ayer, Zahedeh Hatamkhany, Richard G Weyers, Suneel K Gupta, Diane R Guinta, Carol A Christopher, Samuel R Saks, Lawrence G Hamel, Jeri D Wright: Methods and devices for providing prolonged drug therapy. ALZA Corporation, Baker & Hostetler, April 7, 2015: US09000038 (2 worldwide citation)

Methods and devices for maintaining a desired therapeutic drug effect over a prolonged therapy period are provided. In particular, oral dosage forms that release drug within the gastrointestinal tract at an ascending release rate over an extended time period are provided. The dosage forms may additi ...


66
Atul D Ayer, Dana Ridzon: Tandospiaine antidepressive therapy. Alza Corporation, Paul L Sabatine, Edward L Mandell, Jean M Duvall, July 19, 1994: US05330762 (2 worldwide citation)

A dosage form is provided for administering a drug of the formula ##STR1## to a patient to produce an anxiolytic benefit in the patient.


67
Atul D Ayer, Felix Theeuwes, Patrick S L Wong: Improvement in pulsed drug therapy. ALZA Corporation, Paul L Sabatine, Jacqueline S Larson, Jean M Duvall, April 6, 1993: US05200196 (2 worldwide citation)

A dosage form comprising (1) an immediately available dose of a beneficial drug followed by a timed delayed dose of drug, or (2) a timed delayed dose of drug.


68
Atul D Ayer, Dana Ridzon: Dosage form for treating cyclothymia. ALZA Corporation, Paul L Sabatine, Edward L Mandell, Jean M Duvall, September 21, 1993: US05246710 (1 worldwide citation)

A dosage form is provided for administering a drug of the formula ##STR1## to a patient to produce an anxiolytic benefit in the patient.


69
Atul D Ayer, Dana Ridzon: Dosage form for treating dysthymia. ALZA Corporation, Paul L Sabatine, Edward L Mandell, Jacqueline S Larson, September 21, 1993: US05246711 (1 worldwide citation)

A dosage form is provided for administering a drug of the formula ##STR1## to a patient to produce an anxiolytic benefit in the patient.


70
Richard G Weyers, Atul D Ayer, Brenda J Pollock, Brian L Barclay, Ernest S Quan: Nutritional support system. ALZA Corporation, Paul L Sabatine, Susan K Thomas, Michael J Rafa, July 20, 1999: US05925015 (1 worldwide citation)

A nutritional system is disclosed, for delivering a colorant dye to a nutritional fluid that flows through the nutritional system.